Results 211 to 220 of about 25,964,170 (220)

Beta-adrenergic receptor agonists induce the release of granulocyte chemotactic protein-2, oncostatin M, and vascular endothelial growth factor from macrophages

International Immunopharmacology, 2006
Richard J Rodenburg, Kitty Verhoeckx, Renger Witkamp   +2 more
exaly  

Potent benzimidazolone based human β-adrenergic receptor agonists

Bioorganic and Medicinal Chemistry Letters, 2006
Thomas W Stephens
exaly  

Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension

Basic Research in Cardiology, 2016
Rodrigo Fernandez-Jimenez, Jaume Aguero, Manuel Castellà   +2 more
exaly  

The Role of Beta-Adrenergic Receptor Blockers in Alzheimer’s Disease: Potential Genetic and Cellular Signaling Mechanisms

American Journal of Alzheimer's Disease and Other Dementias, 2013
Lan Thi Hoang Nguyen, Khanh Vinh Quoc Luong   +1 more
exaly  

Asthma Beliefs and Overuse of Short-Acting Beta-adrenergic Receptor Agonists Among Older Adults

Journal of Asthma
Jonathan Feldman, Juan P Wisnivesky
exaly  

Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists.

Journal of Pharmacology and Experimental Therapeutics, 1983
A S Nies, J G Gerber, P B Molinoff
exaly  

Clinical Use of -adrenergic Receptor Agonists Based on Their Intrinsic Efficacy

Allergology International, 2005
Hiroaki Kume
exaly  

Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications

Kidney International, 2017
George L King, Hyunjin Noh, I-Hsien Wu
exaly  

Potent oxindole based human β adrenergic receptor agonists

Bioorganic and Medicinal Chemistry Letters, 2007
exaly  

Discovery of potent and orally bioavailable heterocycle-based β-adrenergic receptor agonists, potential therapeutics for the treatment of obesity

Bioorganic and Medicinal Chemistry Letters, 2007
exaly